Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 3
Submit an article Journal homepage
144
Views
1
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetis and Metabolism

Pharmacokinetics and tolerability of cinitapride in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study

Xiong ZhangDepartment of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China; View further author information
,
Ying WangSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China; View further author information
,
Junlin ChengDepartment of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China; View further author information
,
Yunfang HuDepartment of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China; View further author information
,
Jianghui LiuDepartment of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China; View further author information
,
Jing ChenXenoBiotic Laboratories China, Nanjing, Jiangsu, ChinaView further author information
,
Xingye YangXenoBiotic Laboratories China, Nanjing, Jiangsu, ChinaView further author information
&
Hongwei FanDepartment of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China; Correspondence[email protected]
View further author information
 show all
Pages 313-321 | Received 20 Dec 2017, Accepted 28 Feb 2018, Published online: 28 Mar 2018

References

  • Baqai MT, Malik MN, Ziauddin F. (2013). Efficacy and safety of cinitapride in functional dyspepsia. J Pak Med Assoc 63:747–51.
  • Demoly P, Hillaire-Buys D. (2004). Classification and epidemiology of hypersensitivity drug reactions. Immunol Allergy Clin North Am 24:345–56.
  • Du Y, Su T, Song X, et al. (2014). Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia. Clin Gastroenterol 48:328–35.
  • Hemalatha PV, Jerad Suresh A, Niraimathi V. (2013). Spectrophotometric methods for the estimation of cinitapride and pantoprazole in bulk and oral dosage form. ACAIJ 12:120–5.
  • Marcelín-Jiménez G, Contreras L, Esquivel J, et al. (2017). Development of an UPLC–MS/MS micromethod for quantitation of cinitapride inplasma and its application in a pharmacokinetic interaction trial. Bioanalysis 9:569–79.
  • Marquez H, Albertí J, Salvà M, et al. (2011). Development of a UHPLC method for the assessment of the metabolic profile of cinitapride. J Sep Sci 34:3502–8.
  • Moayyedi P, Mason J. (2002). Clinical and economic consequences of dyspepsia in the community. Gut 50:410–2.
  • Parkman HP. (2017). Upper GI disorders: pathophysiology and current therapeutic approaches. Handb Exp Pharmacol 239:17–37.
  • Portincasa P, Mearin F, Robert M, et al. (2009). Efficacy and tolerability of cinitapride in the treatment of functional dyspepsia and delayed gastric emptying. Gastroenterol Hepatol 32:669–76.
  • Robert M, Salvá M, Segarra R, et al. (2007). The prokinetic Cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during co-administration with ketoconazole. Drug Metabol Disp 35:1149–56.
  • Roy SM, Yetal SM, Chavan SV, et al. (2008). Determination of free levels of cinitapride in human plasma by liquid chromatography-tandem mass spectrometry. Eur J Chem 5:453–60.
  • Sturm A, Holtmann G, Goebell H, et al. (1999). Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 60:422–7.
  • Totah RA, Rettie AE. (2005). Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance. Clin Pharmacol Ther 77:341–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.